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a b s t r a c t
Mitochondria are essential for ensuring numerous fundamental physiological processes such as cellular
energy, redox balance, modulation of Ca2+ signaling and important biosynthetic pathways. They also
govern the cell fate by participating in the apoptosis pathway.
The mitochondrial shape, volume, number and distribution within the cells are strictly controlled. The
regulation of these parameters has an impact onmitochondrial function, especially in the central nervous
system, where trafﬁcking of mitochondria is critical to their strategic intracellular distribution, presum-
ably according to local energy demands. Thus, the maintenance of a healthy mitochondrial population
is essential to avoid the impairment of the processes they regulate: for this purpose, cells have devel-
oped mechanisms involving a complex system of quality control to remove damaged mitochondria, or to
renew them. Defects of these processes impair mitochondrial function and lead to disordered cell func-
tion, i.e., to a disease condition. Given the standard role of mitochondria in all cells, it might be expected
that their dysfunction would give rise to similar defects in all tissues. However, damaged mitochondrial
function has pleiotropic effects in multicellular organisms, resulting in diverse pathological conditions,
ranging from cardiac and brain ischemia, to skeletal muscle myopathies to neurodegenerative diseases.
In this review, we will focus on the relationship between mitochondrial (and cellular) derangements and
Ca2+ dysregulation in neurodegenerative diseases, emphasizing the evidence obtained in genetic models.
Common patterns, that recognize the derangement of Ca2+ and energy control as a causative factor, have
been identiﬁed: advances in the understanding of the molecular regulation of Ca2+ homeostasis, and on
the ways in which it could become perturbed in neurological disorders, may lead to the development of
therapeutic strategies that modulate neuronal Ca2+ signaling.. Mitochondria in neuronal Ca2+ homeostasis
Ca2+ is the main second messenger that helps the biochemical
achinery of neurons to connect their depolarization status with
ynaptic activity, which is theirmost crucial activity. Thus, neurons
ave developed extensive and intricate Ca2+ signaling pathways
o cope with the requirement. Neuronal Ca2+ signals are mainly
enerated by the inﬂux through the voltage dependent or ligand
ctivated Ca2+ channels, such as ionotropic glutamate receptors
VOCs and ROCs) [1]. The release of Ca2+ from intracellular stores
i.e. the endo/sarcoplasmic reticulum, ER/SR) by the opening of
he inositol 1,4,5 trisphosphate (InsP3R) and the ryanodine (RyR)
eceptors contributes to the transmission of Ca2+ signals [2]. The
trict control of intracellular Ca2+ concentration is operated by
a2+ binding proteins and by energy demanding Ca2+ transport
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proteins. The plasma membrane Ca2+ ATPase (PMCA) and the
plasma membrane Na+/Ca2+ exchanger (NCX) extrude Ca2+ into
the extracellular space (however, the NCX can also operate in the
reverse mode). The Ca2+ pumps of the intracellular organelles, i.e.,
the ER/SR Ca2+ATPase (SERCA) and the secretory pathway Golgi
Ca2+ ATPase (SPCA) pumps, accumulate Ca2+ in the intracellular
stores [3]. Mitochondria also contribute to the spatiotemporal
tuning of the cytosolic Ca2+ concentration thanks to Ca2+ uptake
and release systems. The transport of Ca2+ by these systems
controls how much Ca2+ enters the cell, the Ca2+ concentration in
cytoplasmic microdomains, the frequency of oscillatory cytosolic
Ca2+ signals and the rate of propagation of a Ca2+ signal. In turn,
mitochondria use their Ca2+ transporting activity to modulate the
rate of ATP synthesis in a number of ways, i.e., by activating Krebs
cycle (TCA) dehydrogenases, by promoting the supply of oxidizable
substrates and by regulating the activity of the ATP synthase [4,5].
The electron transport chain (ETC), i.e., the molecular machin-
ery for energy production, is organized in ﬁve protein complexes
located in the inner mitochondrial membrane. Three of these com-
plexes (I, III, IV) pump protons (H+) across the inner membrane,
thus establishing the electrochemical gradient which is then used
7 alcium
b
a
t
F
t
r
g
(
d
h
h
t
e
m
t
d
l
m
o
a
(
a
d
m
i
H
o
T
e
o
h
t
o
a
p
e
t
m
i
m
o
a
v
s
c
p
m
i
d
m
p
p
a
t
l
c
C
i
t
n
[
t4 T. Calì et al. / Cell C
y complex V, the ATP synthase, to produce ATP. During their
ctivity, electrons are transported from the reduced substrates,
hat accepted reducing equivalents from the TCA cycle (NADH and
ADH2), to the oxygen which is converted to H2O. The electron
ransport, especially in complex I and III, also generates the free
adical superoxide (O2−•), most of which is converted to hydro-
en peroxide (H2O2) by the manganese superoxide dismutase
MnSOD). H2O2 is in turn converted to water by glutathione peroxi-
ase and catalase. However, it can also generate the highly reactive
ydroxyl radical (OH•) by reacting with Fe2+ or Cu2+. Another
ighly reactive species, the peroxynitrite (ONOO−), is produced by
he reaction of O2−• with nitric oxide, and free radicals may  be gen-
rated by the activity of the outer mitochondrial membrane (OMM)
onoamine oxidases (MAOA and MAOB), enzymes involved in
he metabolism of amines like serotonin, norepinephrine and
opamine. All these oxygen reactive species can induce membrane
ipid peroxidation (damaging protein and DNA) or nitration of
itochondrial proteins at tyrosine residues, with consequent loss
f function. However, it must be underlined that O2−• and H2O2
lso serve important signaling functions in physiological processes
for a comprehensive review see Schon and Przedborski [6]).
The ETC, by generating the electrochemical gradient and, in turn,
 difference of membrane potential across the inner mitochon-
rial membrane, also sustains Ca2+ transfer into the mitochondrial
atrix which occurs downhill the gradient through a low afﬁn-
ty uniporter. Two antiporters, the Na+/Ca2+ exchanger and the
+/Ca2+ exchanger, move Ca2+ out of the matrix, allowing the return
f mitochondrial Ca2+ to basal values after cell stimulation [7].
hus, impaired abilities of neurons to maintain appropriate cellular
nergy levels, and increased generation of mitochondrial reactive
xygen species (ROS) may  affect Ca2+ signaling.
The functional properties of mitochondrial Ca2+ transporters
ave been extensively characterized, and very recently some of
hem, i.e. the mitochondrial Ca2+ uniporter (MCU), as well as one
f its regulators (MICU1), and the Na+/Ca2+ antiporter (NCLX) have
lso been molecularly identiﬁed [8–11]. Fig. 1 summarizes the main
layers in mitochondrial Ca2+ transport.
Mitochondrial Ca2+ accumulation depends on the proton
lectrochemical gradient that drives its rapid accumulation
hrough MCU  that, upon cell stimulation, becomes exposed to
icrodomains of high Ca2+ concentration generated by the open-
ng of the Ca2+ channels in the membrane of the ER. The Ca2+
icrodomains are sensed by the MCU  thanks to the close contact
f mitochondria with the ER Ca2+ channels and match its low Ca2+
fﬁnity [12]. The tethers linking the ER and mitochondria have been
isualized [13] and, more recently, mitofusin 2 has been demon-
trated to be an essential component of these structures [14]. The
oncept of mitochondria tethering has been extended also to the
lasma membrane and the Golgi compartment [15,16].
In addition to the Ca2+ transporting systems on the inner
itochondrial membrane (IMM), recent data have revealed an
mportant role of the OMM  permeability. Attention has been
rawn to the potential role of a large-conductance channel, com-
only referred to as the mitochondrial permeability transition
ore (mPTP), in modulating mitochondrial Ca2+. As to the patho-
hysiological role, mPTP is most likely involved in the swelling
nd fragmentation of the mitochondrial network that underlie
he release of caspase cofactors from mitochondria. Its molecu-
ar identity is still unknown, but it appears to be a multiprotein
omplex activated by various pathophysiological conditions (e.g.
a2+ increases in the mitochondrial matrix and oxidation of crit-
cal cysteins). The putatively essential components/regulators are
he voltage dependent anion channel (VDAC) of the OMM,  the ade-
ine nucleotide transporter (ANT) of the IMM  and cyclophilin D
17]. Interestingly, it has been shown that VDAC channels clus-
ered at the ER/mitochondrial contact sites to play a key role in 52 (2012) 73– 85
the rapid transfer of the high Ca2+ microdomain from the surface
of mitochondria to the intermembrane space to which the MCU  is
exposed [18]. VDAC shuttles between open and closed states (with
reference to metabolite transport) and in the closed state shows a
higher permeability to Ca2+. Remarkably, Ca2+ itself appears to con-
trol the conductance of VDAC, thus suggesting that, during the Ca2+
signal, the OMM  barrier is dynamically reduced and mitochondrial
Ca2+ uptake facilitated.
2. Mitochondrial Ca2+ dysregulation and affected processes
Moderate increases in mitochondrial Ca2+ concentration are
necessary and sufﬁcient to adjust ATP production to cell demand,
but mitochondrial Ca2+ overload (MCO) unequivocally leads to
disruption of mitochondrial membrane integrity, permeability
transition, irreversible oxidative damage and loss of ATP pro-
duction, ﬁnally emerging in cell death in different pathological
conditions. MCO  can result essentially from three mechanisms: (i)
increased mitochondrial Ca2+ uptake, following release from the
ER and Ca2+ inﬂux from the extracellular space; (ii) reduced Ca2+
extrusion through the mitochondrial Na+/Ca2+ exchanger; and (iii)
changes of mitochondrial Ca2+ buffering. However, before MCO cul-
minates in cell death, mitochondrial Ca2+ dysregulation originates
in a plethora of disturbances that cells try to control by modulating
mitochondrial Ca2+ related activities. In the following sections we
will discuss them with respect to their regulation by Ca2+, bear-
ing in mind that they represent the mitochondrial quality control
system. Their impairment is a hallmark of the initial phases of neu-
rodegeneration.
2.1. Mitochondrial trafﬁcking and fusion/ﬁssion
The dynamic properties of mitochondria are critical to all cells
but may  be particularly important in neurons, due to their unique
morphology. Synaptic mitochondria clear Ca2+ from the cyto-
sol either by directly taking it up or by providing ATP for the
Ca2+ extrusion (PMCA and NCX) and uptake (SERCA) systems.
Thus, mitochondrial movements and fusion/ﬁssion processes are
required, not only during cell division to properly distribute mito-
chondria to daughter cells, but also to transport mitochondria to
their potential sites of action. At the molecular level, mitochon-
drial dynamics are mediated by three GTPases, namely mitofusins
(Mfn1/2), optic atrophy1 (OPA1) and dynamin related protein 1
(Drp1), which are responsible for the mitochondrial fusion/ﬁssion
process, and by the kinesin and dynein motors that, through the
action of the adaptor protein Milton and the atypical GTPase
Miro, mediate the traveling of mitochondria along cytoskeletal
tracks. These two  pathways are strictly connected since the bal-
ance between mitochondrial ﬁssion and fusion governs the shape
and the number of mitochondria, but also their function and distri-
bution. Intriguingly, Ca2+ acts as the common molecular switch for
both processes [19,20].
Mfns are integral OMM  proteins and mediate mitochondrial
fusion, together with OPA1. OPA1 is located in the intermembrane
space, and, by interacting with the IMM,  promotes its fusion and
cristae remodeling. The process requires a proton gradient, thus
mitochondria that are metabolically compromised are prevented
from fusing. Mitochondrial ﬁssion is governed by the action of Drp1,
which is recruited to mitochondria by several post-translational
modiﬁcations such as phosphorylation and sumoylation. Ca2+ con-
trols Drp1-dependent ﬁssion through calcineurin and CaM-kinase
activities, but also by a Miro-dependent Ca2+ induced mechanism
that enhances fusion at resting Ca2+ concentration, and promotes
fragmentation at high Ca2+ levels [21], thus linking the motility pro-
cess to fusion/ﬁssion. As to Mfns, no direct link with Ca2+ regulation
T. Calì et al. / Cell Calcium 52 (2012) 73– 85 75
Fig. 1. The main players in mitochondrial Ca2+ transport. Ca2+ ﬂows into the cytoplasm upon cell stimulation and the opening of the inositol trisphosphate receptors
(InsP3R), the ryanodine receptors (RyR) at the ER/SR membranes and/or of the plasma membrane associated voltage (VOC), receptor (ROC) and store (SOC) operated calcium
channels. The generation of localized high Ca2+ concentration microdomains drives Ca2+ into the mitochondrial matrix via the mitochondria Ca2+ uniporter (MCU), this
action  being potentiated by the voltage-dependent anion channel (VDAC) that, through GRP75, enhanced the ER Ca2+ transfer. MICU1 is a MCU associated protein that
acts  as MCU  regulator. The efﬂux mechanism depends on the activity of the H+/Ca2+ and the Na+/Ca2+ exchangers. Increased mitochondrial Ca2+ concentration stimulates
TCA  cycle enzymes generating NADH and increasing ATP synthesis and ROS production. Sustained increases in mitochondrial Ca2+ concentration sensitize mitochondria to
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uter  mitochondrial membrane; IMS, intermembrane mitochondrial space; IMM,  in
as been proposed. However, it must be taken into account that
fn2 has been shown to favor ER-mitochondria tethering, implying
hat it could modulate the ER-mitochondria Ca2+ transfer through
his physical coupling [14]. As to the motility process, Miro pro-
eins are anchored to the OMM,  interact with Milton and kinesin
otors and, thanks to the presence of two Ca2+ binding EF-motifs in
he cytosolic domain, they confer Ca2+ sensitivity to mitochondrial
rafﬁcking.
.2. Mitochondrial Ca2+ buffering
Recent work by different groups has clariﬁed that the role of
itochondrial Ca2+ uptake is not limited to the control of organelle
unction, but also has a direct impact on the Ca2+ signals evoked
y agonist stimulation in the cytosol. Seminal observation in stud-
es by Friel and Tsien [22] in bullfrog sympathetic neurons showed
hat a FCCP-sensitive store may  inﬂuence the degree of activation
f intracellular Ca2+-dependent processes. Two mechanisms are
esponsible for this effect. The ﬁrst operates in the microdomains
here mitochondria and Ca2+ channels come in close contact. Here,
he efﬁciency of mitochondrial Ca2+ accumulation accounts for the
apid clearing of the high Ca2+ concentration at the mouth of the
elease channels, and thus reduces the (positive or negative) feed-
ack effect of the cation on the channel itself [15,23]. Thus, this
lose co-positioning on one hand allows the MCU  to rapidly import
arge amounts of Ca2+ into the lumen of the organelle (and thus to
rovide cellular ATP to fuel energy-requiring processes) and, on the
ther hand, to modulate Ca2+ channels activity. The strategic distri-
ution of mitochondria in the different cell compartments is criticalcyt c) and induction of apoptosis. Cytosolic Ca2+ clearance depends on the activity
ger (NCX) and of the ER/SR Ca2+ATPase (SERCA). ER, Endoplasmic reticulum; OMM,
itochondrial membrane.
in the regulation and may  differ among cells types. In HeLa and GH3
cells, the activation of capacitative Ca2+ entry mechanism (CCE)
results in no differences in mitochondrial Ca2+ uptake between the
organelles population close to the plasma membrane and in that
more deeply located, suggesting that mitochondria are excluded
from the regions where the store operated Ca2+ channels (SOCs) are
located and/or activated [24]. Indeed, electron microscopy analysis
in RBL-1 mast cells has revealed that very few mitochondria were
found beneath the plasma membrane, and that SOCs activation
failed to change their pattern of distribution [25]. In T cells, mito-
chondria migrate instead to cell periphery following Ca2+ entry,
thus acting as Ca2+ buffers and preventing SOCs inactivation [26].
The second mechanism by which mitochondrial Ca2+ uptake
affects cytosolic Ca2+ signals has been initially demonstrated in
pancreatic acinar cells, but has been also shown in neurons [27].
Pancreatic acinar cells have a deﬁned polarized morphology, and
the occurrence of cellular Ca2+ signals in different cellular locations
has different physiological consequences. The spreading of the Ca2+
signal is prevented by clustered mitochondria that accumulate
Ca2+, thus acting as a “ﬁrewall”. When mitochondrial “buffering” is
overwhelmed (e.g. upon intense cell stimulation, or when the Ca2+
uptake ability of mitochondria is impaired), Ca2+ can freely diffuse
to the rest of the cell, with physiological and pathological conse-
quences. In addition to prevent the propagation of a Ca2+signal,
mitochondria can also delay its propagation to speciﬁc cellular
compartments, i.e. to the nucleus, thus having a role in the con-
trol of gene expression [28]. For example, Ca2+ uptake and release
from mitochondria generate prolonged cytosolic Ca2+ elevations
that trigger the nuclear import of the transcription factor NFAT
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nuclear factor of activated T-cells), which has a role in synaptic
lasticity, axonal growth, and neuronal survival [29]. Furthermore,
he localization of mitochondria in cell districts where other Ca2+
emoval systems are scarce or absent, for example in dendrites or
xons, represents a key element in the Ca2+ handling.
.3. Mitophagy: organelle-selective autophagic process
Autophagy degrades cellular components by encapsulating
hem in a double-membrane structure, the autophagosome, which
uses with lysosomes [30]. In this way, autophagy recycles intracel-
ular components to compensate for nutrient deprivation, but also
electively eliminates organelles or protein aggregates to main-
ain quality control. Recently, selective mitochondrial autophagy,
nown as mitophagy, has been proposed as a principal mechanism
or damaged mitochondria removal. The selective mitochon-
ria elimination prevents the cytotoxic release of pro-apoptotic
olecules and the extension of mitochondrial damage to the entire
itochondrial population. Mitophagy is generally preceded by
itochondrial ﬁssion [31], which implies that the regulation of
itochondria shape is an essential aspect of mitochondrial quality
ontrol.
Different Ca2+-signaling related proteins have been identiﬁed
n the molecular toolkit of autophagy. Ca2+ has a dual role, being
oth pro-autophagic and anti-autophagic in different situations.
utophagy appears directly dependent on the levels of ER Ca2+ and
n the activity of InsP3R. However, there are opposite views on
ts action. The antiapoptotic proteins Bcl-2 and Bcl-XL have been
eported to mediate the decrease of the ER Ca2+ levels, and of the
a2+ release, thus being protective against apoptotic cell death [32].
hese proteins have also been shown to inhibit autophagy by low-
ring ER Ca2+ levels [33] and by interacting with both the InsP3R and
he autophagic protein beclin 1. Thus, Bcl-2 proteins may  have an
nhibitory role on both apoptotic and autophagic pathways. How-
ver, the mechanisms which trigger these events are yet to be
lucidated. On one hand, it has been shown that the constitutive
a2+ transfer from ER to mitochondria through the InsP3R essen-
ial to sustain mitochondrial function and bioenergetics [34]: when
his signal was abolished, the increased AMP/ATP ratio promoted
MPK activation and stimulation of autophagy [34]. On the other
and, however, it has been reported that elevation of cytosolic Ca2+
y agents which deplete the ER Ca2+ store resulted in increased
utophagy, and that the addition of the Ca2+ buffer BAPTA-AM pre-
ented its induction [35]. An interesting model has been proposed
o reconcile the inhibitory and the stimulatory role of Ca2+ signal
n autophagy: in healthy cells, spontaneous InsP3-mediated Ca2+
elease from the ER is essential to sustain mitochondria bioen-
rgetics. When this signal is missing, ATP depletion accounts for
ctivation of autophagy. Instead, under stress situation, Ca2+ signal-
ng is enhanced and elevated cytosolic Ca2+ stimulates autophagic
ux (for a detailed discussion of these aspects see the comprehen-
ive review by Parys and co-workers [36]).
As to mitochondria, several pathways indicate their possible
ink with the autophagic machinery. General consensus has been
eached that two proteins, the mitochondrial serine/threonine
inase PINK1 and the E3 ubiquitin ligase parkin, the mutations of
hich are the major cause of autosomal recessive familial Parkin-
on’s disease, are key to directing mitochondria to the mitophagy
rocess. They are proposed to function in the same pathway, with
INK1 acting upstream of parkin, and being responsible for parkin
ecruitment to mitochondria by a kinase-dependent mechanism
37]. Once parkin has reached the OMM,  it ubiquinates a series
f targets among which mitofusins, [38–40], Drp1 [41], VDAC1
40,42], and Bcl-2 [43], suggesting that these changes could be
arly events in the process of mitophagy. Very recently, it has also
een shown that PINK1 phosphorylates Miro, thus promoting its 52 (2012) 73– 85
proteasomal degradation by triggering parkin [44]. This ﬁnding
is particularly intriguing since the Miro yeast homolog has been
shown to regulate the ER-mitochondria contact sites [45].
Thus, PINK1 phosphorylation of substrates may  represent a nec-
essary early event that triggers the subsequent action of parkin
and of the proteasome. Whether mitochondrial Ca2+ dysregulation
could be relevant in these actions remains an unexplored possibility
that has been suggested by the studies on the roles of PINK1/parkin
(see below, Section 3.2).
2.4. Mitochondrial pathway for apoptotic cell death
Apoptosis (programmed cell death) occurs in all multicellular
organisms during normal tissue development, and its dysregula-
tion is responsible for the origin of many pathological conditions
neurodegeneration and cancer.
The Ca2+ link with the apoptotic pathways has been established
clearly by the ﬁnding that the anti-apoptotic Bcl-2 protein lowers
the Ca2+ ER content and that Ca2+ can sensitize cells to apoptotic
challenges, acting on the mitochondrial checkpoint [32]. The ﬁnd-
ing that Bcl-2, in addition to being localized in the cytoplasm and
at the nuclear envelope, is also associated to the ER and mitochon-
drial membranes further reinforced the link. Bcl-2 and Bcl-XL, the
other anti-apoptotic member of Bcl-2 family, directly interact with
the InsP3R on the ER membrane, and sensitize it to low agonist
doses, promoting the leakage of Ca2+ from ER. These effects are
reverted by overexpression of the pro-apoptotic protein Bax [46].
The knock down of Bax and of Bak, another pro-apoptotic Bcl-2
family member protein, reduces the Ca2+ content of the ER; instead,
Bax overexpression increases it [47,48]. Accordingly, double knock-
out Bax/Bak mouse embryonic ﬁbroblasts (MEF) are resistant to
apoptotic stimuli [49].
The amount of Ca2+ released from the ER is critical to the trans-
duction of the signal in mitochondria and the modulation of the
InsP3R opening by pro or antiapoptotic proteins is a key element
that determines mitochondrial changes in physio/pathological
responses. Mitochondria are the depositories of proapoptotic pro-
teins like Smac/DIABLO, Omi/HtrA2, AIF and EndoG which are in
equilibrium with the antiapoptotic proteins XIAP, cIAP-1 and cIAP-
2, their relationship ﬁnely regulating cell death and life balance.
Thus, the role of mitochondria and Ca2+ is an essential determinant:
Ca2+ loads in the matrix sensitize the mPTP to apoptotic stimuli,
inducing its opening, mitochondrial changes in morphology, and
the release of cytochrome c [50] and caspase activation [51,52].
Numerous studies have also established a link between mito-
chondrial dynamics and the apoptotic pathway. Loss of mitofusins
and OPA1 leads to mitochondrial fragmentation and enhances sen-
sitivity to cell death stimuli, while their overexpression leads to
increased survival in neurons [53,54].  The molecular basis of this
action could be traced back to the cytochrome c release and caspase
activation induced by mitochondrial fragmentation. Interestingly,
however, Bax and Bak proteins have been found to associate
with components of the ﬁssion/fusion machinery suggesting their
mutual cross-talk [55].
3. Mitochondrial Ca2+ dysregulation and
neurodegenerative diseases: the cause or the consequence?
Neurodegenerative diseases are a large group of heterogeneous
disorders characterized by the selective death of neuronal subtypes.
A number of studies suggest that the alteration of Ca2+ homeosta-
sis is a hallmark of these pathologies; in particular, Ca2+-dependent
mitochondrial dysfunction, defects in morphology and trafﬁcking
may  be critical to the degeneration of neurons in Alzheimer’s (AD),
Parkinson’s (PD) and Huntington’s (HD) diseases, in amyotrophic
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ateral sclerosis (ALS) and in demyelinating diseases [56–61].  The
olecular etiology of AD is causally related to the altered synap-
ic bioenergetics and function. Cognitive defects in AD patients
orrelate with the loss of dendritic spines and synapses [62], and
lterations in mitochondrial function [61], morphology and dynam-
cs [63–65] are particularly important. As to PD, our understanding
f the molecular mechanisms has dramatically improved after the
iscovery of rare familial forms linked to mutations in LRRK2,
-synuclein (-syn), parkin, DJ-1 and PINK1. Functional studies
uggest that these proteins have important roles in regulating the
alance between mitochondrial ﬁssion/fusion processes [66,67]
nd in controlling mitochondria motility along microtubules [44].
n HD mitochondrial abnormalities and oxidative damage, defects
n the activity of complex II (and III) of the respiratory chain have
een observed, and it has been proposed that mutant huntingtin
ay  sensitize mPTP opening in model cells, thus disrupting mito-
hondrial Ca2+ homeostasis and increasing the susceptibility to
poptotic stimuli [68,69].
As to ALS, the familial cases are related to mutations in the mito-
hondrial Cu/Zn superoxide dismutase (SOD1) gene, which result
n the alteration of complex II and IV of the respiratory chain, and
ossibly in the abnormal structure and number of mitochondria in
otor neurons and in skeletal muscles [70].
The evidence that mitochondrial abnormalities and oxidative
amage play a central role in the pathogenesis of several neu-
odegenerative diseases is thus well supported. The molecular
eterminants of the defects, however, are still debated. The pos-
ibility that dysregulation of the mitochondrial Ca2+ could be a
ommon feature of the molecular etiology of these diseases is now
aining momentum. The different neurodegenerative pathologies
ill be discussed separately in the next sections.
.1. Alzheimer’s disease
AD is the ﬁrst cause of dementia in aged people worldwide.
t begins with mild, slowly progressing loss of memory and then
ontinued with debilitating symptoms such as complete loss of
ognitive abilities and bodily functions, ultimately leading to death.
lthough AD cases are mostly sporadic, with the symptoms ﬁrst
ppearing after age 60, a small fraction of cases (1–2%) is genet-
cally inherited and characterized by an early age of onset (<60).
hree genes, namely the amyloid-precursor protein (APP) and the
resenilin-1 and 2 genes (PSEN-1 and 2), have been identiﬁed as
esponsible for the Familial forms of Alzheimer’s disease (FAD).
he study of their gene products has allowed to gain new insights
n the pathogenic mechanisms of the condition [71]. Sporadic and
amilial AD are both characterized by the presence of extracellular
myloid plaques. They are composed of aggregates of amyloid 
A) peptides derived from the amyloid precursor protein (APP)
leavage by the - and -secretase, and intracellular neuroﬁb-
illary tangles, formed by ﬁlaments of hyperphosphorylated tau
rotein [72,73].  Based on the toxicity evoked by the deposition of
 aggregates, the amyloidogenic pathway has been proposed as
he main pathological event at the basis of the AD pathogenesis
74]. However, the ﬁnding that the oligomeric soluble fraction of
he A protein [75], rather than the ﬁbrillar and insoluble form, is
rucial to the impairment of the cognitive function [76] has led to
he possibility of an alternative hypothesis. Disturbances in Ca2+
ignaling have been found in both sporadic [77,78] and familial
ases of AD [79]. The development of a Ca2+ dysregulation hypoth-
sis was supported by the ﬁnding that A oligomers can insert
n the plasma membrane and form ion conducting channels, thus
ossibly mediating excitotoxicity by enhancing Ca2+ inﬂux [80]
nd eventual neurodegeneration [81]. Fig. 2 summarizes the main
ndings on this issue. A oligomers have been found to induce
assive Ca2+ transfer between ER and mitochondria [82] and 52 (2012) 73– 85 77
mitochondrial Ca2+ overload [83]. Altered mitochondrial morphol-
ogy and/or distribution have been found in neurons from brains of
AD patients [84,85] and in model cells upon A [86], APP [87] and
FAD-Presenilin-1 [88] expression. Excessive Ca2+ taken up into
mitochondria increases ROS production, inhibits ATP synthesis,
induces the opening of the mPTP, and the release of cytochrome c,
triggering the initiation of apoptosis [89,90].  A can also accumu-
late in mitochondria and interact with speciﬁc intra-mitochondrial
targets, directly leading to the dysfunction of this organelle [91].
A study on brain mitochondria from an AD animal model has
shown that A interacts with Cyclophilin D (CypD) and promotes
the opening of the mPTP, thereby causing neuronal injury and
a decline in cognitive functions. Accordingly, genetic ablation of
CypD renders brain mitochondria more resistant to mPTP opening
[92], suggesting it could represent a potential therapeutic target.
The “Ca2+ hypothesis” is also strongly supported by studies on
FAD. It has been shown that mutated presenilins (PSs) may con-
tribute to the dysregulation of Ca2+ homeostasis that, in turn, may
be responsible for the mitochondrial impairment observed in AD
[86]. PS1 and PS2 are located in different intracellular compart-
ments such as the ER, the Golgi apparatus [93], and mitochondria,
where they participate to the formation of active -secretase
complexes [94,95].  They have been proposed to function as low
conductance Ca2+-leak channels in the ER membrane, thus con-
tributing to maintain physiological Ca2+ concentration within the
ER. Mutations causing AD have been shown to abrogate this chan-
nel activity, and result in enhanced ER Ca2+ levels and, following cell
stimulation, increased cytosolic Ca2+ transients [96,97]. Neverthe-
less, a number of studies have instead observed either no alteration
or reduced ER Ca2+ levels in FAD PS-expressing cells [79,98–101].
These studies have proposed that, rather to function as Ca2+ leak
channels, PS are able to modulate Ca2+ leak by modulating InsP3Rs
and/or RyRs permeability [102] and, possibly, by reducing SERCA
activity [103]. FAD mutant PS1 and PS2 have been shown to inter-
act with the InsP3R and to enhance Ca2+ release from the ER at low
physiological concentrations of agonist [104,105],  thus reducing ER
Ca2+ content rather than augmenting it. Interestingly, PSs have been
found to be enriched in the ER-mitochondrial-associated mem-
branes (MAM)  [106] and, it is worth mentioning that the T122R PS2
mutation has been shown to enhance the ER-mitochondria teth-
ering [107]. Thus, two opposite scenarios can be envisaged: the
increased ER-mitochondria interaction could potentially result in
toxic mitochondrial Ca2+ overload or, alternatively, it could result
in a compensatory phenomenon to ensure proper Ca2+ signaling to
mitochondria when ER Ca2+ levels are reduced. On the other hand,
it must also be taken into account that the enhanced recruitment of
mitochondria close to ER could be simply the consequence of dys-
functional Ca2+ handling by the store, since mitochondria dynamics
is tightly regulated by Ca2+.
3.2. Parkinson’s disease
PD is the second most common progressing neurodegenerative
disorder. It is characterized by the progressive loss of dopamin-
ergic neurons in the substantia nigra pars compacta and by
the accumulation of intracellular inclusions called Lewy bodies.
Like the AD, most of the cases of PD are sporadic and prob-
ably caused by environmental toxins, but about 5–10% of the
cases are of genetic origin. Evidence linking mitochondrial dys-
functions and oxidative stress with PD originated from a seminal
study on chemically induced Parkinsonism in 1983, in which drug
addicts were shown to develop rapid onset PD-like symptoms after
injection of heroin contaminated with 1-methyl-4-phenyl-1,2,3,6-
tetra-hydropyridine (MPTP) [108]. The study demonstrated that
the active metabolite of MPTP was a potent inhibitor of complex I of
the respiratory chain and a substrate of the dopamine transporter.
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Fig. 2. Mitochondrial dysfunctions and Ca2+ homeostasis in AD. Peptide -amyloid (A)  oligomers affect mitochondrial functionality either by increasing cytosolic Ca2+ con-
centration through a pore-forming mechanism at the plasma membrane and/or by enhancing ER Ca2+ release. Possible mitochondrial A accumulation impairs mitochondrial
energy metabolism, leading to mitochondrial oxidative damage. A may  sensitize mPTP opening by interacting with cyclophilin D (CypD). FAD-linked mutant presenilins
(PSs)  may  alter the expression/sensitivity of ER Ca2+ release channels (RyR and InsP3R) leading to an exaggerated ER Ca2+ release and abnormal mitochondrial Ca2+ uptake.
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[ reduction in SERCA activity has also been described. Wild-type PSs, but not the FA
een  found in mitochondria.
t accumulated in dopaminergic neurons to which it conferred toxi-
ity and eventually produced cell death. Further studies on humans
nd on animal models exposed to the complex I inhibitors rotenone,
araquat and 6-hydroxydopamine (6-OHDA) have linked mito-
hondrial exposure to toxins to the degeneration of dopaminergic
eurons, dopamine depletion, and increased oxidative stress [109].
he subsequent discovery of hereditary forms of PD caused by dom-
nant and recessive mutations in nuclear genes encoded proteins
unctionally related to mitochondria has added additional impor-
ance to the study of mitochondrial dysfunction in PD [110]. The
roducts of two dominantly inherited genes, -synuclein (-syn)
nd LRRK2 (dardarin), and of several autosomal recessive inherited
enes, DJ-1, parkin, PINK1, and Omi/HTRA2, have been found to be
ocalized in, and/or to interfere with, mitochondria. The number
f reports on this relationship is increasing exponentially: general
onsensus has now been reached on the role of PINK1/parkin in the
egulation of mitophagy (see above), and emerging evidence indi-
ates that also -syn and DJ-1 may  participate in the pathways of
itochondrial quality control by regulating mitochondrial shape.
Very few papers have considered the possibility that these pro-
eins may  also interfere with mitochondrial Ca2+ signaling. The
roposed mechanisms by which this could occur are schematized
n Fig. 3. -syn has been described to modulate Ca2+ inﬂux, sug-
esting that its oligomers could enhance the plasma membrane
on permeability [111] either by becoming directly inserted into
he plasma membrane to form a pore [112], or by modulating the
pen probability of the plasma membrane Ca2+ channels [113].
owever, the link with the PD pathogenesis is still missing, and
ontroversial effects have been reported on the intracellular Ca2+
ncrease by PD-related -syn mutants [111,113].  Recent studies
ave shown that -syn can associate to mitochondria and that its
ccumulation increases mitochondrial Ca2+ levels and, as a con-
equence, nitric oxide levels, oxidative damage and cytochrome c
elease [114]. However, these observations are controversial [115]
nd we have obtained evidence that -syn plays a dual oppo-
ite role on the modulation of mitochondrial Ca2+ accumulation
epending on its level of expression and its intracellular distribu-
ion [116]. We  have recently reported that moderate level of -syn
verexpression enhances mitochondrial Ca2+ homeostasis by aug-
enting ER-mitochondria contact sites thus, possibly, sustaining
ell bioenergetics. Accordingly, -syn “loss of function” impaired
itochondrial Ca2+ transients and enhanced autophagic process
116]. Interestingly, it has been recently shown that glial cellstants, were reported to form Ca2+ permeable leak channels in the ER. PSs have also
obtained from the mesencephalon of mice overexpressing mutated
human -syn, displayed severe mitochondrial damage, including
morphological changes and reduced Ca2+-storage capacity [117]:
the reduced mitochondrial Ca2+ buffering capacity could, in turn,
lead to an increase in cytosolic Ca2+ with consequent calpain acti-
vation [118].
DJ-1 is a multifunctional protein and, despite its predominant
role as an antioxidant [119], it also appears to have a role in main-
taining the cytosolic basal Ca2+ concentration and to permit the
depolarization-induced Ca2+ release from the SR in muscle cells
[120]. An interesting link between DJ-1, Ca2+ handling and mito-
chondria has been reported by studies of the properties of L-type
voltage dependent Ca2+ channels of dopaminergic neurons of the
substantia nigra. These channels are characterized by a speciﬁc pore
forming subunit (Cav1.3) which confers to the channel the prop-
erty to be opened at relatively hyperpolarized potentials, allowing
them to sustain the pacemaking activity which characterises these
neurons [121]. The sustained engagement of these channels dur-
ing pacemaking activity has an obvious high metabolic cost, and
induces a very large Ca2+ penetration into the neurons. Surmeier
and co-workers have elegantly demonstrated that, in dopaminergic
neurons, the enhanced Ca2+ entry created an oxidant stress in mito-
chondria that thus became speciﬁcally vulnerable. Interestingly,
the situation was  further exacerbated by DJ-1 knockout, implying
an essential role of DJ-1 in protecting dopaminergic neurons by
Ca2+-induced mitochondrial uncoupling and ROS production dur-
ing physiological pace-making [122].
More compelling evidence for a possible role of mitochondrial
Ca2+ dysfunction in the pathogenesis of PD comes from studies
on the mitochondrial kinase PINK1. The ﬁrst suggestions arose
from the ﬁnding that the expression of mutant, but not of wt,
PINK1 exacerbated the mitochondrial defects observed in a cellu-
lar model of PD expressing mutated A53T -syn. The defects, i.e.,
loss of m, increased mitochondrial size with loss of cristae and
reduced ATP levels, were partially recovered by cyclosporine A and,
fully rescued by the inhibitor of MCU  ruthenium red, thus lead-
ing to the suggestion that mitochondrial Ca2+ uptake was involved
[123]. Other studies have expanded the investigation of the role
of PINK1 in mitochondrial Ca2+ metabolism, but the results are
controversial. In one case the absence of PINK1 induced mito-
chondrial Ca2+ accumulation, possibly as a consequence of the
impairment of mitochondrial Ca2+ efﬂux through the mitochon-
drial Na+/Ca2+ exchanger [124]. In another study, PINK1 depletion
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Fig. 3. Mitochondrial dysfunctions and Ca2+ homeostasis in PD. -syn monomers impair complex I and complex III activity, while oligomeric -syn has been shown to
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itochondrial Na+/Ca2+ exchanger and/or of the MCU. Additionally, together with p
ttenuates protein misfolding and may  protect against apoptotic stimuli, by preven
mpaired mitochondrial Ca2+ uptake (with no effect on Ca2+ extru-
ion) and consequently ATP production [125]. Further studies are
vidently necessary to clarify the molecular targets of PINK1 action.
owever, it is interesting to note that an increased sensitivity of
itochondria to Ca2+-induced permeability has been shown to pre-
ede dopaminergic defects in PINK1-deﬁcient mice, suggesting that
itochondrial Ca2+ degeneration could be an early event in the
athogenesis of PD [126].
.3. Huntington’s disease
HD is an autosomal-dominant disease characterized by the loss
f striatal GABAergic neurons. Major symptoms are motility impair-
ent (chorea), dementia, and other neuropsychiatric defects. The
enetic cause is the abnormal expansion of CAG repeats (corre-
ponding to a poly-glutamine stretch (poly-Q)) in exon 1 of the gene
oding for Huntingtin protein (Htt). The mutant forms of Htt con-
ain more than 35 repeats and there is a direct correlation between
he number of glutamines over 35 and the severity of the disease.
tt is a large protein (348 kDa) mainly localized in the cytosol, but it
s also found in the ER, mitochondria, nucleus and Golgi compart-
ent. Its function is presently unclear, although its involvementS and sustain complex I activity. PINK1, possibly, modulates the activity of the
it acts as a sensor to direct damaged mitochondria to the mitophagy process. Parkin
he opening of mPTP.
has been suggested in cellular pathways like transcription reg-
ulation, mitochondrial function, ROS production, apoptosis and
organelles trafﬁcking [127,128].  It is, nevertheless, essential to
life: its homozygous deletion causes death at the embryonic age
in mice, and its heterozygous deletion causes neurodegeneration
[129]. The role of the poly-Q expansion at the N-terminal is not
known, but it has been reported that its ablation in mice ame-
liorates motor/behavioral deﬁcits, and extends lifespan [130]. The
poly-Q expansion is cleaved off proteolitically, caspase 6 being
most likely responsible for the cleavage [131]. The cleaved frag-
ments increase probability of protein misfolding events and show
propensity to aggregate and to form ﬁbrils and oligomers [132,133].
However, whether the Htt fragment aggregates play a role in HD
pathogenesis, and whether the oligomers (and/or aggregates) are
toxic or protective, is still debated [133,134].  The link between Ca2+
homeostasis and HD has been established in a number of studies,
most of them focused on mitochondrial Ca2+ handling dysfunction.
The results have been controversial and no unequivocal conclu-
sion can be drawn. Fig. 4 summarizes the main pathways that have
been proposed, and a succinct overview of the data present in the
literature will be presented here. As it was found in other neurode-
generative diseases, mitochondria isolated from lymphoblast of HD
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Fig. 4. Mitochondrial dysfunctions and Ca2+ homeostasis in ALS and HD. Mutant SOD1 in ALS and mutant Htt in HD enhance intracellular Ca2+ permeability, impair mito-
chondrial membrane potential and increase the susceptibility to mitochondrial Ca2+ overload, thus inducing mPTP opening, the release of cytochrome c (cyt c) and apoptosis.
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eading to an augmented mitochondrial Ca2+ uptake. Increased mitochondrial Ca2+
TP  synthesis and ROS production.
atients and from the brain of HD mice models have impaired abil-
ty to take up Ca2+. They are more susceptible to Ca2+ overload,
ith the vulnerability proportional to the length of the mutant
tt poly-Q expansion [135,136].  The matrix Ca2+ overload favors
PTP opening, which has been shown to be prevented by CsA in
tudies on mitochondria isolated from striatal neurons express-
ng mutant Htt [137] and from muscle of HD model R6/2 mice
138]. These ﬁndings have been conﬁrmed also in cultured cells,
.g., the expression of mutant Htt in mouse immortalized striatal
ells made mitochondria unable to handle large Ca2+ loads, very
ikely because of induced mPTP opening. The observed decrease
f mitochondrial Ca2+, appears to be a compensatory attempt to
revent the mitochondrial Ca2+ stress that would irreversibly dam-
ge the organelles and eventually lead to cell death [69]. However,
he ablation of cyclophilin D in HD mouse models failed to induce
ny improvement in the disease progression, despite the increased
a2+-buffering capacity of their mitochondria [139–141]. These
ontroversial ﬁndings are possibly related to the different exper-
mental conditions, but also to the loss of the contribution of the
R compartment in experiments performed in isolated mitochon-
ria. In fact, a number of reports have described the involvement
f ER Ca2+ handling in HD cellular models. Htt was shown to inﬂu-
nce intracellular Ca2+ signaling by acting on the InsP3R activity
nd expression [69,142–144], and striatal precursors of HD neurons
isplay increased Ca2+ content in the ER [145] that could compro-
ise mitochondria Ca2+ handling. Another aspect of mitochondrian other neurodegenerative diseases is shared by HD: the mitochon-
rial ﬁssion/fusion balance is affected by the presence of mutant Htt
n different HD models, possibly as a consequence of the enhanced
alcineurin activity, and thus of the calcineurin-dependent Drp1ound associated with mutant forms of ALS) enhances ER-mitochondria tethering,
entration, in turn, stimulates TCA cycle enzymes generating NADH and increasing
recruitment to mitochondria. The enhanced mitochondria frag-
mentation led to enhanced apoptotic sensitivity, thus accounting
for an early role of Ca2+ dysregulation in the death of striatal neu-
rons [145].
3.4. Amyotrophic lateral sclerosis
ALS is a neurodegenerative disease caused by the progressive
loss of motor neurons in motor cortex, brain stem and spinal cord
[146]. Like other neurodegenerative disease, ALS presents alter-
ations of mitochondrial morphology and function, accumulation of
phosphorylated neuroﬁlaments in the axons and somatic accumu-
lation of protein inclusions formed by TDP-43 (TAR DNA binding
protein-43) and ubiquitin [147–149]. ALS is a sporadic disease and
despite several hypotheses implicating oxidative stress, protea-
some dysfunction, glutamatergic excitotoxicity and mitochondria
dysfunction, its etiology remains elusive [150]. However, in the
last years, several mutations in some proteins were identiﬁed to
be causally related to familial forms of ALS: among them, those in
superoxide dismutase 1 (SOD1) are the most frequent, accounting
for the 20% of the familial cases [151]. As previously mentioned,
SOD1 is key enzyme in the defense against oxidative stress, as it
converts the superoxide anion in hydrogen peroxide. It has been
proposed that its mutations could cause a gain of toxic function
[147]. At the moment, the best model for the study of the disease
is represented by transgenic mice expressing mutant SOD1 [150].To understand the role of Ca2+ dysfunction in ALS, it is impor-
tant to underline that ALS-vulnerable motor neurons, like spinal
and brain stem neurons, have very low Ca2+ buffering capacity as
compared to not-vulnerable neurons. This speciﬁc characteristic
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protein of the inner membrane is the mitochondrial calcium uniporter, NatureT. Calì et al. / Cell C
ccounts for the rapid and low cost recovery of Ca2+ transients
hat, in physiological condition, is necessary for the rapid relaxation
imes during high-frequency rhythmic activity. However, under
athological conditions it may  generate the appearance of high
a2+ concentration microdomains that would account for exci-
otoxic cell damage [152]. Another interesting characteristic of
hese neurons is their enrichment in Ca2+-permeable glutamate
MPA-receptor channels. Under overstimulation, they mediate
lutamate-excitotoxicity, which results in selective motor neuron
egeneration and death [153–155]. The Ca2+ permeability of AMPA
eceptor is regulated by the GluR2 subunit, and motor neurons
xpress low amount of GluR2 mRNA in comparison with other
eurons [156–158]. The GluR2 expression level is regulated by the
strocytes surrounding the motor neurons, and its Ca2+ permeabil-
ty is controlled by a mechanism of RNA editing that replaces a
ositively charged arginine with a neutral glutamine, thus making
he channel impermeable to Ca2+. Reduced editing results in acute
eurodegeneration in mice and, accordingly, defective editing was
etected in motor neurons of individuals affected by sporadic ALS
159]. The absence of the GluR2 subunit accelerated motor neu-
ons degeneration in mutant SOD1 mice, whereas the induction
f GluR2 expression increased life span of these mice [160,161].  It
as also been shown that mutant SOD1 augmented AMPA receptor
ermeability to Ca2+ [162].
Experimental evidence shows enhancement of glutamate in
otor neurons of patients affected by sporadic and genetic ALS
163,164] possibly due to the loss of the astroglial glutamate trans-
orter GLT1 and thus to a decrease of glutamate uptake by the
urrounding astrocytes. However, contrasting ﬁndings have shown
hat the chronic elevation of glutamate by the impairment of its
ransport has no effect on spinal motor neurons in vivo [165].
In the last years an increasing number of papers pointed out
he importance of mitochondrial dysfunctions, in particular of
efects in the electron transport chain and in the morphology
f the organelles, both in sporadic and familial ALS [166]. Fig. 4
ummarizes the main ﬁndings. As previously discussed, different
itochondrial populations may  be strategically located close to
he ER or to the plasma membrane Ca2+ channels to promptly
uffer high Ca2+ microdomains generated by cell stimulation. This
spect is of particular relevance for neuronal cells that undergo
ontinuous stimulation [167], and especially for motor neurons
hat have reduced levels of Ca2+ buffering proteins, like paravalbu-
in, calbindin, etc. [168,169].  Although not numerous, the studies
n mitochondria support a causative role for Ca2+ overload in
eurons from individuals affected by sporadic and genetic ALS.
itochondria at the synapse of motoneurons of mutant SOD1
ice display a greater membrane potential depolarization after
a2+ uptake, in line with the proposal that the Ca2+-buffering
apacity of these organelles could be compromised [170]. Accord-
ngly, the overexpression of mutant SOD1 in neuroblastoma cells
ncreases the cytosolic Ca2+ level [171]. Emerging evidence thus
upports the MCO  hypothesis, in which mPTP opening, cytochrome
 release, and activation of the apoptotic cascade are direct con-
equences. Interestingly, the ablation of cyclophilin D in SOD1
utant mice delays disease onset, and CsA treatment is beneﬁcial
172,173].
Finally, it is appropriate to mention another interesting pos-
ibility that may  link mitochondrial Ca2+ dysfunction to ALS
athogenesis: the vesicle-associated membrane protein (VAMP)-
ssociated protein B (VAPB) has been found to be mutated in
amilial ALS [174]. VAPB is an ER membrane anchored-protein
hich exposed its C-terminal domain on the cytosolic side [175]
nd has been reported to induce ER-stress and consequent Ca2+-
ediated death in motor neurons [176]. It has then been found
hat VAPB is enriched in the MAMs,  where it interacts with
TPIP51 (a mitochondrial outer membrane protein) and, where it 52 (2012) 73– 85 81
is necessary to support ER-mitochondria Ca2+ transfer, since its
siRNA-mediated silencing disrupts Ca2+ signaling between these
two organelles [175]. Interestingly, a mutant form of VAPB (P56S),
but not the wild-type protein, induces mitochondria clustering,
impaired mitochondria Ca2+ uptake and increased cytosolic Ca2+
levels. In turn, these alterations result in an impairment of the
anterograde axonal transport of mitochondria towards the cell
periphery [177].
4. Conclusions
The picture emerging from the study of the pathogenesis of
neurodegenerative conditions appears extremely complex and
multifaceted. Intriguingly, common elements are shared by most
of them making crucial to investigate on these aspects. Defects in
the respiratory chain and oxidative stress have been recognized
in almost all neurodegenerative disorders. However, reviewing the
most recent literature, they do not appear as the primary cause,
but rather the result of impaired mitochondria function. Compro-
mised mitochondrial quality control and Ca2+ handling are instead
suggested to be primary events. Therefore, any approach aimed
at the modulation of mitochondrial dynamics and/or stimulation
of mitochondrial biogenesis may  be beneﬁcial for the treatment
of the diseases. Targeting mitochondrial Ca2+ dysregulation may
represent a great challenge, at least to delay the insurgence of neu-
rodegenerative symptoms and alleviate their progression. Thus,
both in basic and applied research there is growing interest on
this topic, further accentuated by the recent identiﬁcation of key
molecules (the NCX, MICU1, a uniporter regulator and MCU,  the
uniporter itself).
Conﬂict of interest statement
No conﬂict of interest statement.
Acknowledgements
The authors wish to thank Ernesto Carafoli (Venetian Insti-
tute of Molecular Medicine, Padova, Italy) for critical reading the
manuscript.
Work performed by the authors on the topic was supported
over the years by grants to M.B. from the Italian National Research
Council (CNR), the Italian Ministry of University and Research (PRIN
2003, 2005 and 2008), the Telethon Foundation (Project GGP04169)
and the local founding of the University of Padova (Progetto di
Ateneo 2008).
References
[1] M.J. Berridge, M.D. Bootman, H.L. Roderick, Calcium signalling: dynamics,
homeostasis and remodelling, Nature Reviews Molecular Cell Biology 4
(2003) 517–529.
[2] M.J. Berridge, Inositol trisphosphate and calcium signalling mechanisms,
Biochimica et Biophysica Acta 1793 (2009) 933–940.
[3]  M.  Brini, E. Carafoli, Calcium pumps in health and disease, Physiological
Reviews 89 (2009) 1341–1378.
[4] C. Mammucari, M.  Patron, V. Granatiero, R. Rizzuto, Molecules and roles of
mitochondrial calcium signaling, Biofactors 37 (2011) 219–227.
[5]  T. Calì, D. Ottolini, M.  Brini, Mitochondrial Ca2+ as a key regulator of
mitochondrial activities. Advances in mitochondrial medicine, Advances in
Experimental Medicine and Biology Series 942 (2012) 53–73.
[6] E.A. Schon, S. Przedborski, Mitochondria: the next (neurode)generation, Neu-
ron  70 (2011) 1033–1053.
[7] I. Drago, P. Pizzo, T. Pozzan, After half a century mitochondrial calcium in- and
efﬂux machineries reveal themselves, EMBO Journal 30 (2011) 4119–4125.
[8]  D. De Stefani, A. Raffaello, E. Teardo, I. Szabo, R. Rizzuto, A forty-kilodalton476  (2011) 336–340.
[9] J.M. Baughman, F. Perocchi, H.S. Girgis, M.  Plovanich, C.A. Belcher-Timme,
et  al., Integrative genomics identiﬁes MCU  as an essential component of the
mitochondrial calcium uniporter, Nature 476 (2011) 341–345.
8 alcium2 T. Calì et al. / Cell C
[10] F. Perocchi, V.M. Gohil, H.S. Girgis, X.R. Bao, J.E. McCombs, et al., MICU1
encodes a mitochondrial EF hand protein required for Ca(2+) uptake, Nature
467  (2010) 291–296.
[11] R. Palty, W.F. Silverman, M.  Hershﬁnkel, T. Caporale, S.L. Sensi, et al., NCLX is
an  essential component of mitochondrial Na+/Ca2+ exchange, Proceedings of
the National Academy of Sciences of the United States of America 107 (2010)
436–441.
[12] R. Rizzuto, M.  Brini, M.  Murgia, T. Pozzan, Microdomains with high Ca2+ close
to  IP3-sensitive channels that are sensed by neighboring mitochondria, Sci-
ence 262 (1993) 744–747.
[13] R. Rizzuto, P. Pinton, W.  Carrington, F.S. Fay, K.E. Fogarty, et al., Close con-
tacts with the endoplasmic reticulum as determinants of mitochondrial Ca2+
responses, Science 280 (1998) 1763–1766.
[14] O.M. de Brito, L. Scorrano, Mitofusin 2 tethers endoplasmic reticulum to mito-
chondria, Nature 456 (2008) 605–610.
[15] M. Hoth, C.M. Fanger, R.S. Lewis, Mitochondrial regulation of store-operated
calcium signaling in T lymphocytes, Journal of Cell Biology 137 (1997)
633–648.
[16] P. Pizzo, V. Lissandron, P. Capitanio, T. Pozzan, Ca(2+) signalling in the Golgi
apparatus, Cell Calcium 50 (2011) 184–192.
[17] F. Ricchelli, J. Sileikyte, P. Bernardi, Shedding light on the mitochondrial per-
meability transition, Biochimica et Biophysica Acta 1807 (2011) 482–490.
[18] G. Szabadkai, K. Bianchi, P. Varnai, D. De Stefani, M.R. Wieckowski, et al.,
Chaperone-mediated coupling of endoplasmic reticulum and mitochondrial
Ca2+ channels, Journal of Cell Biology 175 (2006) 901–911.
[19] X. Liu, G. Hajnoczky, Ca2+-dependent regulation of mitochondrial dynamics
by  the Miro–Milton complex, International Journal of Biochemistry and Cell
Biology 41 (2009) 1972–1976.
[20] A.F. MacAskill, J.T. Kittler, Control of mitochondrial transport and localization
in  neurons, Trends in Cell Biology 20 (2010) 102–112.
[21] M.  Saotome, D. Saﬁulina, G. Szabadkai, S. Das, A. Fransson, et al., Bidirectional
Ca2+-dependent control of mitochondrial dynamics by the Miro GTPase, Pro-
ceedings of the National Academy of Sciences of the United States of America
105 (2008) 20728–20733.
[22] D.D. Friel, R.W. Tsien, An FCCP-sensitive Ca2+ store in bullfrog sympathetic
neurons and its participation in stimulus-evoked changes in [Ca2+]i, Journal
of  Neuroscience 14 (1994) 4007–4024.
[23] I. Bezprozvanny, J. Watras, B.E. Ehrlich, Bell-shaped calcium-response curves
of  Ins(1,4,5)P3- and calcium-gated channels from endoplasmic reticulum of
cerebellum, Nature 351 (1991) 751–754.
[24] M.  Giacomello, I. Drago, M.  Bortolozzi, M.  Scorzeto, A. Gianelle, et al., Ca2+ hot
spots on the mitochondrial surface are generated by Ca2+ mobilization from
stores, but not by activation of store-operated Ca2+ channels, Molecular Cell
38  (2010) 280–290.
[25] M.D. Glitsch, D. Bakowski, A.B. Parekh, Store-operated Ca2+ entry depends on
mitochondrial Ca2+ uptake, EMBO Journal 21 (2002) 6744–6754.
[26] A. Quintana, E.C. Schwarz, C. Schwindling, P. Lipp, L. Kaestner, et al., Sustained
activity of calcium release-activated calcium channels requires translocation
of  mitochondria to the plasma membrane, Journal of Biological Chemistry
281 (2006) 40302–40309.
[27] C. Walsh, S. Barrow, S. Voronina, M.  Chvanov, O.H. Petersen, et al., Modulation
of  calcium signalling by mitochondria, Biochimica et Biophysica Acta 1787
(2009) 1374–1382.
[28] K. Deisseroth, P.G. Mermelstein, H. Xia, R.W. Tsien, Signaling from synapse to
nucleus: the logic behind the mechanisms, Current Opinion in Neurobiology
13  (2003) 354–365.
[29] M.S. Kim, Y.M. Usachev, Mitochondrial Ca2+ cycling facilitates activation of
the transcription factor NFAT in sensory neurons, Journal of Neuroscience 29
(2009) 12101–12114.
[30] Z. Yang, D.J. Klionsky, Mammalian autophagy: core molecular machinery and
signaling regulation, Current Opinion in Cell Biology 22 (2010) 124–131.
[31] G. Twig, A. Elorza, A.J. Molina, H. Mohamed, J.D. Wikstrom, et al., Fission
and selective fusion govern mitochondrial segregation and elimination by
autophagy, The EMBO Journal 27 (2008) 433–446.
[32] P. Pinton, R. Rizzuto, Bcl-2 and Ca2+ homeostasis in the endoplasmic reticu-
lum, Cell Death and Differentiation 13 (2006) 1409–1418.
[33] J.M. Vicencio, C. Ortiz, A. Criollo, A.W. Jones, O. Kepp, et al., The inositol 1,4,5-
trisphosphate receptor regulates autophagy through its interaction with
Beclin 1, Cell Death and Differentiation 16 (2009) 1006–1017.
[34] C. Cardenas, R.A. Miller, I. Smith, T. Bui, J. Molgo, et al., Essential regulation of
cell bioenergetics by constitutive InsP3 receptor Ca2+ transfer to mitochon-
dria, Cell 142 (2010) 270–283.
[35] K. Sakaki, J. Wu,  R.J. Kaufman, Protein kinase Ctheta is required for autophagy
in  response to stress in the endoplasmic reticulum, The Journal of Biological
Chemistry 283 (2008) 15370–15380.
[36] J.P. Decuypere, G. Bultynck, J.B. Parys, A dual role for Ca(2+) in autophagy
regulation, Cell Calcium 50 (2011) 242–250.
[37] Y. Imai, B. Lu, Mitochondrial dynamics and mitophagy in Parkinson’s disease:
disordered cellular power plant becomes a big deal in a major movement
disorder, Current Opinion in Neurobiology 21 (2011) 935–941.
[38] A. Tanaka, M.M.  Cleland, S. Xu, D.P. Narendra, D.F. Suen, et al., Proteasome and
p97 mediate mitophagy and degradation of mitofusins induced by Parkin,
Journal of Cell Biology 191 (2010) 1367–1380.
[39] M.E. Gegg, J.M. Cooper, K.Y. Chau, M.  Rojo, A.H. Schapira, et al., Mitofusin 1
and mitofusin 2 are ubiquitinated in a PINK1/parkin-dependent manner upon
induction of mitophagy, Human Molecular Genetics 19 (2010) 4861–4870. 52 (2012) 73– 85
[40] N.C. Chan, A.M. Salazar, A.H. Pham, M.J. Sweredoski, N.J. Kolawa, et al.,
Broad activation of the ubiquitin-proteasome system by Parkin is critical for
mitophagy, Human Molecular Genetics 20 (2011) 1726–1737.
[41] H. Wang, P. Song, L. Du, W.  Tian, W.  Yue, et al., Parkin ubiquitinates Drp1
for proteasome-dependent degradation: implication of dysregulated mito-
chondrial dynamics in Parkinson disease, Journal of Biological Chemistry 286
(2011) 11649–11658.
[42] S. Geisler, K.M. Holmstrom, D. Skujat, F.C. Fiesel, O.C. Rothfuss, et al.,
PINK1/Parkin-mediated mitophagy is dependent on VDAC1 and p62/SQSTM1,
Nature Cell Biology 12 (2010) 119–131.
[43] D. Chen, F. Gao, B. Li, H. Wang, Y. Xu, et al., Parkin mono-ubiquitinates
Bcl-2 and regulates autophagy, Journal of Biological Chemistry 285 (2010)
38214–38223.
[44] X. Wang, D. Winter, G. Ashraﬁ, J. Schlehe, Y.L. Wong, et al., PINK1 and Parkin
Target Miro for phosphorylation and degradation to arrest mitochondrial
motility, Cell 147 (2011) 893–906.
[45] B. Kornmann, C. Osman, P. Walter, The conserved GTPase Gem1 regu-
lates endoplasmic reticulum-mitochondria connections, Proceedings of the
National Academy of Sciences of the United States of America 108 (2011)
14151–14156.
[46] C. White, C. Li, J. Yang, N.B. Petrenko, M.  Madesh, et al., The endoplasmic
reticulum gateway to apoptosis by Bcl-X(L) modulation of the InsP3R, Nature
Cell Biology 7 (2005) 1021–1028.
[47] N.N. Danial, S.J. Korsmeyer, Cell death: critical control points, Cell 116 (2004)
205–219.
[48] M.  Chami, A. Prandini, M.  Campanella, P. Pinton, G. Szabadkai, et al., Bcl-2
and Bax exert opposing effects on Ca2+ signaling, which do not depend on
their putative pore-forming region, Journal of Biological Chemistry 279 (2004)
54581–54589.
[49] L. Scorrano, S.A. Oakes, J.T. Opferman, E.H. Cheng, M.D. Sorcinelli, et al., BAX
and  BAK regulation of endoplasmic reticulum Ca2+: a control point for apo-
ptosis, Science 300 (2003) 135–139.
[50] P. Pacher, G. Hajnoczky, Propagation of the apoptotic signal by mitochondrial
waves, EMBO Journal 20 (2001) 4107–4121.
[51] G. Kroemer, J.C. Reed, Mitochondrial control of cell death, Nature Medicine 6
(2000) 513–519.
[52] P. Pinton, C. Giorgi, R. Siviero, E. Zecchini, R. Rizzuto, Calcium and apoptosis:
ER-mitochondria Ca2+ transfer in the control of apoptosis, Oncogene 27 (2008)
6407–6418.
[53] A. Jahani-Asl, E.C. Cheung, M.  Neuspiel, J.G. MacLaurin, A. Fortin,
et  al., Mitofusin 2 protects cerebellar granule neurons against injury-
induced cell death, The Journal of Biological Chemistry 282 (2007)
23788–23798.
[54] M.J. Barsoum, H. Yuan, A.A. Gerencser, G. Liot, Y. Kushnareva, et al.,
Nitric oxide-induced mitochondrial ﬁssion is regulated by dynamin-related
GTPases in neurons, The EMBO Journal 25 (2006) 3900–3911.
[55] A. Jahani-Asl, M.  Germain, R.S. Slack, Mitochondria: joining forces to thwart
cell death, Biochimica et Biophysica Acta 1802 (2010) 162–166.
[56] H.C. Lee, Y.H. Wei, Mitochondrial role in life and death of the cell, Journal of
Biomedical Science 7 (2000) 2–15.
[57] D.T. Chang, G.L. Rintoul, S. Pandipati, Reynolds IJ, Mutant huntingtin aggre-
gates impair mitochondrial movement and trafﬁcking in cortical neurons,
Neurobiology of Disease 22 (2006) 388–400.
[58] M.  Forte, B.G. Gold, G. Marracci, P. Chaudhary, E. Basso, et al., Cyclophilin D
inactivation protects axons in experimental autoimmune encephalomyelitis,
an animal model of multiple sclerosis, Proceedings of the National Academy
of  Sciences of the United States of America 104 (2007) 7558–7563.
[59] A. Weihofen, K.J. Thomas, B.L. Ostaszewski, M.R. Cookson, D.J. Selkoe, Pink1
forms a multiprotein complex with Miro and Milton, linking Pink1 function
to  mitochondrial trafﬁcking, Biochemistry 48 (2009) 2045–2052.
[60] M.P. Mattson, M.  Gleichmann, A. Cheng, Mitochondria in neuroplasticity and
neurological disorders, Neuron 60 (2008) 748–766.
[61] G.L. Rintoul, I.J. Reynolds, Mitochondrial trafﬁcking and morphology in neu-
ronal injury, Biochimica et Biophysica Acta 1802 (2010) 143–150.
[62]  G.M. Shankar, D.M. Walsh, Alzheimer’s disease: synaptic dysfunction and
Abeta, Molecular Neurodegeneration 4 (2009) 48.
[63] K. Iijima-Ando, S.A. Hearn, C. Shenton, A. Gatt, L. Zhao, et al., Mitochon-
drial mislocalization underlies Abeta42-induced neuronal dysfunction in a
Drosophila model of Alzheimer’s disease, PLoS One 4 (2009) e8310.
[64] X.L. Zhao, W.A. Wang, J.X. Tan, J.K. Huang, X. Zhang, et al., Expression of
beta-amyloid induced age-dependent presynaptic and axonal changes in
Drosophila, Journal of Neuroscience 30 (2010) 1512–1522.
[65] X. Wang, B. Su, H.G. Lee, X. Li, G. Perry, et al., Impaired balance of mitochondrial
ﬁssion and fusion in Alzheimer’s disease, Journal of Neuroscience 29 (2009)
9090–9103.
[66] R.J. Youle, D.P. Narendra, Mechanisms of mitophagy, Nature Reviews Molec-
ular Cell Biology 12 (2011) 9–14.
[67] A.J. Whitworth, L.J. Pallanck, The PINK1/Parkin pathway: a mitochondrial
quality control system? Journal of Bioenergetics and Biomembranes 41 (2009)
499–503.
[68] A.V. Panov, C.A. Gutekunst, B.R. Leavitt, M.R. Hayden, J.R. Burke, et al., Early
mitochondrial calcium defects in Huntington’s disease are a direct effect of
polyglutamines, Nature Neuroscience 5 (2002) 731–736.
[69] D. Lim, L. Fedrizzi, M.  Tartari, C. Zuccato, E. Cattaneo, et al., Calcium homeosta-
sis  and mitochondrial dysfunction in striatal neurons of Huntington disease,
Journal of Biological Chemistry 283 (2008) 5780–5789.
alciumT. Calì et al. / Cell C
[70] L. Faes, G. Callewaert, Mitochondrial dysfunction in familial amyotrophic lat-
eral sclerosis, Journal of Bioenergetics and Biomembranes 43 (2011) 587–592.
[71] M.  Goedert, M.G. Spillantini, A century of Alzheimer’s disease, Science 314
(2006) 777–781.
[72] F.M. LaFerla, K.N. Green, S. Oddo, Intracellular amyloid-beta in Alzheimer’s
disease, Nature Reviews Neuroscience 8 (2007) 499–509.
[73] M.P. Mattson, Pathways towards and away from Alzheimer’s disease, Nature
430 (2004) 631–639.
[74] J. Hardy, D.J. Selkoe, The amyloid hypothesis of Alzheimer’s disease: progress
and problems on the road to therapeutics, Science 297 (2002) 353–356.
[75] A. Demuro, I. Parker, G.E. Stutzmann, Calcium signaling and amyloid tox-
icity in Alzheimer disease, The Journal of Biological Chemistry 285 (2010)
12463–12468.
[76] R. Kayed, E. Head, J.L. Thompson, T.M. McIntire, S.C. Milton, et al., Common
structure of soluble amyloid oligomers implies common mechanism of patho-
genesis, Science 300 (2003) 486–489.
[77] M. Tolar, J.N. Keller, S. Chan, M.P. Mattson, M.A. Marques, et al., Truncated
apolipoprotein E (ApoE) causes increased intracellular calcium and may
mediate ApoE neurotoxicity, The Journal of Neuroscience: The Ofﬁcial Journal
of  the Society for Neuroscience 19 (1999) 7100–7110.
[78] M. Boada, C. Antunez, J. Lopez-Arrieta, J.J. Galan, F.J. Moron, et al., CALHM1
P86L polymorphism is associated with late-onset Alzheimer’s disease in a
recessive model, Journal of Alzheimer’s Disease 20 (2010) 247–251.
[79] G. Zatti, R. Ghidoni, L. Barbiero, G. Binetti, T. Pozzan, et al., The presenilin
2  M239I mutation associated with familial Alzheimer’s disease reduces Ca2+
release from intracellular stores, Neurobiology of Disease 15 (2004) 269–278.
[80] A. Demuro, E. Mina, R. Kayed, S.C. Milton, I. Parker, et al., Calcium dysregu-
lation and membrane disruption as a ubiquitous neurotoxic mechanism of
soluble amyloid oligomers, The Journal of Biological Chemistry 280 (2005)
17294–17300.
[81] Z.S. Khachaturian, Calcium hypothesis of Alzheimer’s disease and brain aging,
Annals of the New York Academy of Sciences 747 (1994) 1–11.
[82] E. Ferreiro, C.R. Oliveira, C.M. Pereira, The release of calcium from the endo-
plasmic reticulum induced by amyloid-beta and prion peptides activates
the mitochondrial apoptotic pathway, Neurobiology of Disease 30 (2008)
331–342.
[83] S. Sanz-Blasco, R.A. Valero, I. Rodriguez-Crespo, C. Villalobos, L. Nunez, Mito-
chondrial Ca2+ overload underlies Abeta oligomers neurotoxicity providing
an  unexpected mechanism of neuroprotection by NSAIDs, PLoS One 3 (2008)
e2718.
[84] K. Hirai, G. Aliev, A. Nunomura, H. Fujioka, R.L. Russell, et al., Mitochondrial
abnormalities in Alzheimer’s disease, The Journal of Neuroscience: The Ofﬁ-
cial Journal of the Society for Neuroscience 21 (2001) 3017–3023.
[85] X. Wang, B. Su, H.G. Lee, X. Li, G. Perry, et al., Impaired balance of mitochondrial
ﬁssion and fusion in Alzheimer’s disease, The Journal of Neuroscience: The
Ofﬁcial Journal of the Society for Neuroscience 29 (2009) 9090–9103.
[86] M.T. Lin, M.F. Beal, Mitochondrial dysfunction and oxidative stress in neu-
rodegenerative diseases, Nature 443 (2006) 787–795.
[87] X. Wang, B. Su, S.L. Siedlak, P.I. Moreira, H. Fujioka, et al., Amyloid-beta
overproduction causes abnormal mitochondrial dynamics via differential
modulation of mitochondrial ﬁssion/fusion proteins, Proceedings of the
National Academy of Sciences of the United States of America 105 (2008)
19318–19323.
[88] G. Pigino, G. Morﬁni, A. Pelsman, M.P. Mattson, S.T. Brady, et al., Alzheimer’s
presenilin 1 mutations impair kinesin-based axonal transport, The Journal of
Neuroscience: The Ofﬁcial Journal of the Society for Neuroscience 23 (2003)
4499–4508.
[89] N. Brustovetsky, J.M. Dubinsky, B. Antonsson, R. Jemmerson, Two path-
ways for tBID-induced cytochrome c release from rat brain mitochondria:
BAK- versus BAX-dependence, Journal of Neurochemistry 84 (2003)
196–207.
[90] D. Jiang, P.G. Sullivan, S.L. Sensi, O. Steward, J.H. Weiss, Zn(2+) induces per-
meability transition pore opening and release of pro-apoptotic peptides
from neuronal mitochondria, The Journal of Biological Chemistry 276 (2001)
47524–47529.
[91]  C. Caspersen, N. Wang, J. Yao, A. Sosunov, X. Chen, et al., Mitochondrial Abeta:
a  potential focal point for neuronal metabolic dysfunction in Alzheimer’s dis-
ease, The FASEB Journal: Ofﬁcial Publication of the Federation of American
Societies for Experimental Biology 19 (2005) 2040–2041.
[92] H. Du, L. Guo, F. Fang, D. Chen, A.A. Sosunov, et al., Cyclophilin D deﬁ-
ciency attenuates mitochondrial and neuronal perturbation and ameliorates
learning and memory in Alzheimer’s disease, Nature Medicine 14 (2008)
1097–1105.
[93]  W.G. Annaert, L. Levesque, K. Craessaerts, I. Dierinck, G. Snellings, et al., Pre-
senilin 1 controls gamma-secretase processing of amyloid precursor protein
in  pre-golgi compartments of hippocampal neurons, Journal of Cell Biology
147 (1999) 277–294.
[94] M. Ankarcrona, K. Hultenby, Presenilin-1 is located in rat mitochondria, Bio-
chemical and Biophysical Research Communications 295 (2002) 766–770.
[95] C.A. Hansson, S. Frykman, M.R. Farmery, L.O. Tjernberg, C. Nilsberth, et al.,
Nicastrin, presenilin, APH-1, and PEN-2 form active gamma-secretase com-
plexes in mitochondria, The Journal of Biological Chemistry 279 (2004)
51654–51660.
[96] H. Tu, O. Nelson, A. Bezprozvanny, Z. Wang, S.F. Lee, et al., Presenilins form
ER Ca2+ leak channels, a function disrupted by familial Alzheimer’s disease-
linked mutations, Cell 126 (2006) 981–993. 52 (2012) 73– 85 83
[97] O. Nelson, H. Tu, T. Lei, M.  Bentahir, B. de Strooper, et al., Familial Alzheimer
disease-linked mutations speciﬁcally disrupt Ca2+ leak function of presenilin
1,  Journal of Clinical Investigation 117 (2007) 1230–1239.
[98] M.  Giacomello, L. Barbiero, G. Zatti, R. Squitti, G. Binetti, et al., Reduction of Ca2+
stores and capacitative Ca2+ entry is associated with the familial Alzheimer’s
disease presenilin-2 T122R mutation and anticipates the onset of dementia,
Neurobiology of Disease 18 (2005) 638–648.
[99] G. Zatti, A. Burgo, M.  Giacomello, L. Barbiero, R. Ghidoni, et al., Presenilin muta-
tions linked to familial Alzheimer’s disease reduce endoplasmic reticulum and
Golgi apparatus calcium levels, Cell Calcium 39 (2006) 539–550.
[100] C.B. Lessard, M.P. Lussier, S. Cayouette, G. Bourque, G. Boulay, The overex-
pression of presenilin2 and Alzheimer’s-disease-linked presenilin2 variants
inﬂuences TRPC6-enhanced Ca2+ entry into HEK293 cells, Cellular Signalling
17  (2005) 437–445.
[101] N.N. Kasri, S.L. Kocks, L. Verbert, S.S. Hebert, G. Callewaert, et al., Up-regulation
of inositol 1,4,5-trisphosphate receptor type 1 is responsible for a decreased
endoplasmic-reticulum Ca2+ content in presenilin double knock-out cells, Cell
Calcium 40 (2006) 41–51.
[102] D. Shilling, D.O. Mak, D.E. Kang, J.K. Foskett, Lack of evidence for presenilins
as  endoplasmic reticulum Ca2+ leak channels, Journal of Biological Chemistry
287 (2012) 10933–10934.
[103] L. Brunello, E. Zampese, C. Florean, T. Pozzan, P. Pizzo, et al., Presenilin-2
dampens intracellular Ca2+ stores by increasing Ca2+ leakage and reducing
Ca2+ uptake, Journal of Cellular and Molecular Medicine 13 (2009) 3358–3369.
[104] K.H. Cheung, D. Shineman, M. Muller, C. Cardenas, L. Mei, et al., Mechanism
of  Ca2+ disruption in Alzheimer’s disease by presenilin regulation of InsP3
receptor channel gating, Neuron 58 (2008) 871–883.
[105] K.H. Cheung, L. Mei, D.O. Mak, I. Hayashi, T. Iwatsubo, et al., Gain-of-
function enhancement of IP3 receptor modal gating by familial Alzheimer’s
disease-linked presenilin mutants in human cells and mouse neurons, Science
Signaling 3 (2010) ra22.
[106] E. Area-Gomez, A.J. de Groof, I. Boldogh, T.D. Bird, G.E. Gibson, et al., Pre-
senilins are enriched in endoplasmic reticulum membranes associated with
mitochondria, American Journal of Pathology 175 (2009) 1810–1816.
[107] E. Zampese, C. Fasolato, M.J. Kipanyula, M.  Bortolozzi, T. Pozzan, et al., Pre-
senilin 2 modulates endoplasmic reticulum (ER)-mitochondria interactions
and Ca2+ cross-talk, Proceedings of the National Academy of Sciences of the
United States of America 108 (2011) 2777–2782.
[108] J.W. Langston, P.A. Ballard Jr., Parkinson’s disease in a chemist working
with 1-methyl-4-phenyl-1,2,5,6-tetrahydropyridine, New England Journal of
Medicine 309 (1983) 310.
[109] F. Cicchetti, N. Lapointe, A. Roberge-Tremblay, M.  Saint-Pierre, L. Jimenez,
et  al., Systemic exposure to paraquat and maneb models early Parkinson’s
disease in young adult rats, Neurobiology of Disease 20 (2005) 360–371.
[110] S. DiMauro, E.A. Schon, Mitochondrial disorders in the nervous system,
Annual Review of Neuroscience 31 (2008) 91–123.
[111] K.M. Danzer, D. Haasen, A.R. Karow, S. Moussaud, M.  Habeck, et al., Differ-
ent  species of alpha-synuclein oligomers induce calcium inﬂux and seeding,
Journal of Neuroscience 27 (2007) 9220–9232.
[112] H.A. Lashuel, B.M. Petre, J. Wall, M.  Simon, R.J. Nowak, et al., Alpha-
synuclein, especially the Parkinson’s disease-associated mutants, forms
pore-like annular and tubular protoﬁbrils, Journal of Molecular Biology 322
(2002) 1089–1102.
[113] K. Furukawa, M.  Matsuzaki-Kobayashi, T. Hasegawa, A. Kikuchi, N. Sugeno,
et  al., Plasma membrane ion permeability induced by mutant alpha-synuclein
contributes to the degeneration of neural cells, Journal of Neurochemistry 97
(2006) 1071–1077.
[114] M.S. Parihar, A. Parihar, M.  Fujita, M.  Hashimoto, P. Ghafourifar, Alpha-
synuclein overexpression and aggregation exacerbates impairment of
mitochondrial functions by augmenting oxidative stress in human neuroblas-
toma cells, International Journal of Biochemistry and Cell Biology 41 (2009)
2015–2024.
[115] N.T. Hettiarachchi, A. Parker, M.L. Dallas, K. Pennington, C.C. Hung, et al.,
alpha-Synuclein modulation of Ca2+ signaling in human neuroblastoma (SH-
SY5Y) cells, Journal of Neurochemistry 111 (2009) 1192–1201.
[116] T. Cali, D. Ottolini, A. Negro, M.  Brini, Alpha-synuclein controls mitochondrial
calcium homeostasis by enhancing endoplasmic reticulum-mitochondria
interactions, Journal of Biological Chemistry 287 (2012) 17914–17929.
[117] S. Schmidt, B. Linnartz, S. Mendritzki, T. Sczepan, M.  Lubbert, et al., Genetic
mouse models for Parkinson’s disease display severe pathology in glial cell
mitochondria, Human Molecular Genetics 20 (2011) 1197–1211.
[118] A.R. Esteves, D.M. Arduino, R.H. Swerdlow, C.R. Oliveira, S.M. Car-
doso, Dysfunctional mitochondria uphold calpain activation: contribution
to  Parkinson’s disease pathology, Neurobiology of Disease 37 (2010)
723–730.
[119] T. Taira, Y. Saito, T. Niki, S.M. Iguchi-Ariga, K. Takahashi, et al., DJ-1 has a
role in antioxidative stress to prevent cell death, EMBO Reports 5 (2004)
213–218.
[120] A. Shtifman, N. Zhong, J.R. Lopez, J. Shen, J. Xu, Altered Ca2+ homeostasis in the
skeletal muscle of DJ-1 null mice, Neurobiology of Aging 32 (2011) 125–132.
[121] J.N. Guzman, J. Sanchez-Padilla, C.S. Chan, D.J. Surmeier, Robust pacemaking
in substantia nigra dopaminergic neurons, The Journal of Neuroscience: The
Ofﬁcial Journal of the Society for Neuroscience 29 (2009) 11011–11019.
[122] J.N. Guzman, J. Sanchez-Padilla, D. Wokosin, J. Kondapalli, E. Ilijic, et al., Oxi-
dant stress evoked by pacemaking in dopaminergic neurons is attenuated by
DJ-1, Nature 468 (2010) 696–700.
8 alcium4 T. Calì et al. / Cell C
[123] R. Marongiu, B. Spencer, L. Crews, A. Adame, C. Patrick, et al., Mutant Pink1
induces mitochondrial dysfunction in a neuronal cell model of Parkinson’s
disease by disturbing calcium ﬂux, Journal of Neurochemistry 108 (2009)
1561–1574.
[124] S. Gandhi, A. Wood-Kaczmar, Z. Yao, H. Plun-Favreau, E. Deas, et al., PINK1-
associated Parkinson’s disease is caused by neuronal vulnerability to calcium-
induced cell death, Molecular Cell 33 (2009) 627–638.
[125] B. Heeman, C. Van den Haute, S.A. Aelvoet, F. Valsecchi, R.J. Roden-
burg, et al., Depletion of PINK1 affects mitochondrial metabolism, calcium
homeostasis and energy maintenance, Journal of Cell Science 124 (2011)
1115–1125.
[126] R.S. Akundi, Z. Huang, J. Eason, J.D. Pandya, L. Zhi, et al., Increased mitochon-
drial calcium sensitivity and abnormal expression of innate immunity genes
precede dopaminergic defects in pink1-deﬁcient mice, PLoS One 6 (2011)
e16038.
[127] The Huntington’s Disease Collaborative Research Group, A novel gene con-
taining a trinucleotide repeat that is expanded and unstable on Huntington’s
disease chromosomes, Cell 72 (1993) 971–983.
[128] M.  Giacomello, R. Hudec, R. Lopreiato, Huntington’s disease, calcium, and
mitochondria, Biofactors 37 (2011) 206–218.
[129] S.A. Thayer, R.J. Miller, Regulation of the intracellular free calcium concentra-
tion in single rat dorsal root ganglion neurones in vitro, Journal of Physiology
425 (1990) 85–115.
[130] S. Zheng, E.B. Clabough, S. Sarkar, M.  Futter, D.C. Rubinsztein, et al., Deletion
of  the huntingtin polyglutamine stretch enhances neuronal autophagy and
longevity in mice, PLoS Genetics 6 (2010) e1000838.
[131] R.K. Graham, Y. Deng, E.J. Slow, B. Haigh, N. Bissada, et al., Cleavage at the
caspase-6 site is required for neuronal dysfunction and degeneration due to
mutant huntingtin, Cell 125 (2006) 1179–1191.
[132] A.J. Williams, H.L. Paulson, Polyglutamine neurodegeneration: protein mis-
folding revisited, Trends in Neurosciences 31 (2008) 521–528.
[133] M. DiFiglia, E. Sapp, K.O. Chase, S.W. Davies, G.P. Bates, et al., Aggregation
of huntingtin in neuronal intranuclear inclusions and dystrophic neurites in
brain, Science 277 (1997) 1990–1993.
[134] D. Martindale, A. Hackam, A. Wieczorek, L. Ellerby, C. Wellington, et al.,
Length of huntingtin and its polyglutamine tract inﬂuences localization
and frequency of intracellular aggregates, Nature Genetics 18 (1998)
150–154.
[135] Y.S. Choo, G.V. Johnson, M.  MacDonald, P.J. Detloff, M.  Lesort, Mutant
huntingtin directly increases susceptibility of mitochondria to the calcium-
induced permeability transition and cytochrome c release, Human Molecular
Genetics 13 (2004) 1407–1420.
[136] F.N. Gellerich, Z. Gizatullina, H.P. Nguyen, S. Trumbeckaite, S. Vielhaber,
et  al., Impaired regulation of brain mitochondria by extramitochondrial Ca2+
in transgenic Huntington disease rats, Journal of Biological Chemistry 283
(2008) 30715–30724.
[137] T. Milakovic, R.A. Quintanilla, G.V. Johnson, Mutant huntingtin expres-
sion induces mitochondrial calcium handling defects in clonal striatal
cells: functional consequences, Journal of Biological Chemistry 281 (2006)
34785–34795.
[138] Z.Z. Gizatullina, K.S. Lindenberg, P. Harjes, Y. Chen, C.M. Kosinski, et al., Low
stability of Huntington muscle mitochondria against Ca2+ in R6/2 mice, Annals
of  Neurology 59 (2006) 407–411.
[139] N. Brustovetsky, R. LaFrance, K.J. Purl, T. Brustovetsky, C.D. Keene, et al.,
Age-dependent changes in the calcium sensitivity of striatal mitochondria in
mouse models of Huntington’s disease, Journal of Neurochemistry 93 (2005)
1361–1370.
[140] J.M. Oliveira, M.B. Jekabsons, S. Chen, A. Lin, A.C. Rego, et al., Mitochondrial
dysfunction in Huntington’s disease: the bioenergetics of isolated and in situ
mitochondria from transgenic mice, Journal of Neurochemistry 101 (2007)
241–249.
[141] G.M. Perry, S. Tallaksen-Greene, A. Kumar, M.Y. Heng, A. Kneynsberg, et al.,
Mitochondrial calcium uptake capacity as a therapeutic target in the R6/2
mouse model of Huntington’s disease, Human Molecular Genetics 19 (2010)
3354–3371.
[142] L.S. Kaltenbach, E. Romero, R.R. Becklin, R. Chettier, R. Bell, et al., Huntingtin
interacting proteins are genetic modiﬁers of neurodegeneration, PLoS Genet-
ics 3 (2007) e82.
[143] T.S. Tang, H. Tu, E.Y. Chan, A. Maximov, Z. Wang, et al., Huntingtin and
huntingtin-associated protein 1 inﬂuence neuronal calcium signaling medi-
ated by inositol-(1,4,5) triphosphate receptor type 1, Neuron 39 (2003)
227–239.
[144] H. Zhang, Q. Li, R.K. Graham, E. Slow, M.R. Hayden, et al., Full length mutant
huntingtin is required for altered Ca2+ signaling and apoptosis of striatal
neurons in the YAC mouse model of Huntington’s disease, Neurobiology of
Disease 31 (2008) 80–88.
[145] V. Costa, M. Giacomello, R. Hudec, R. Lopreiato, G. Ermak, et al., Mitochon-
drial ﬁssion and cristae disruption increase the response of cell models of
Huntington’s disease to apoptotic stimuli, EMBO Molecular Medicine 2 (2010)
490–503.
[146] L.M. Duffy, A.L. Chapman, P.J. Shaw, A.J. Grierson, Review: the role of
mitochondria in the pathogenesis of amyotrophic lateral sclerosis, Neu-
ropathology and Applied Neurobiology 37 (2011) 336–352.
[147] P. Pasinelli, R.H. Brown, Molecular biology of amyotrophic lateral sclero-
sis:  insights from genetics, Nature Reviews Neuroscience 7 (2006) 710–
723. 52 (2012) 73– 85
[148] P.C. Wong, C.A. Pardo, D.R. Borchelt, M.K. Lee, N.G. Copeland, et al., An adverse
property of a familial ALS-linked SOD1 mutation causes motor neuron disease
characterized by vacuolar degeneration of mitochondria, Neuron 14 (1995)
1105–1116.
[149] T. Arai, M.  Hasegawa, H. Akiyama, K. Ikeda, T. Nonaka, et al., TDP-43 is a com-
ponent of ubiquitin-positive tau-negative inclusions in frontotemporal lobar
degeneration and amyotrophic lateral sclerosis, Biochemical and Biophysical
Research Communications 351 (2006) 602–611.
[150] P.A. Dion, H. Daoud, G.A. Rouleau, Genetics of motor neuron disorders: new
insights into pathogenic mechanisms, Nature Reviews Genetics 10 (2009)
769–782.
[151] D.R. Rosen, T. Siddique, D. Patterson, D.A. Figlewicz, P. Sapp, et al., Mutations
in  Cu/Zn superoxide dismutase gene are associated with familial amyotrophic
lateral sclerosis, Nature 362 (1993) 59–62.
[152] F. von Lewinski, B.U. Keller, Ca2+, mitochondria and selective motoneuron vul-
nerability: implications for ALS, Trends in Neurosciences 28 (2005) 494–500.
[153] C. Ikonomidou, Y. Qin Qin, J. Labruyere, J.W. Olney, Motor neuron degener-
ation induced by excitotoxin agonists has features in common with those
seen in the SOD-1 transgenic mouse model of amyotrophic lateral sclerosis,
Journal of Neuropathology and Experimental Neurology 55 (1996) 211–224.
[154] J.D. Rothstein, L. Jin, M.  Dykes-Hoberg, R.W. Kuncl, Chronic inhibition of glu-
tamate uptake produces a model of slow neurotoxicity, Proceedings of the
National Academy of Sciences of the United States of America 90 (1993)
6591–6595.
[155] S.G. Carriedo, S.L. Sensi, H.Z. Yin, J.H. Weiss, AMPA exposures induce mito-
chondrial Ca(2+) overload and ROS generation in spinal motor neurons in
vitro, Journal of Neuroscience 20 (2000) 240–250.
[156] P. Van Damme, L. Van Den Bosch, E. Van Houtte, G. Callewaert, W. Robberecht,
GluR2-dependent properties of AMPA receptors determine the selective vul-
nerability of motor neurons to excitotoxicity, Journal of Neurophysiology 88
(2002) 1279–1287.
[157] P.R. Heath, J. Tomkins, P.G. Ince, P.J. Shaw, Quantitative assessment of AMPA
receptor mRNA in human spinal motor neurons isolated by laser capture
microdissection, Neuroreport 13 (2002) 1753–1757.
[158] Y. Kawahara, S. Kwak, H. Sun, K. Ito, H. Hashida, et al., Human spinal motoneu-
rons express low relative abundance of GluR2 mRNA: an implication for
excitotoxicity in ALS, Journal of Neurochemistry 85 (2003) 680–689.
[159] Y. Kawahara, K. Ito, H. Sun, H. Aizawa, I. Kanazawa, et al., Glutamate receptors:
RNA editing and death of motor neurons, Nature 427 (2004) 801.
[160] P. Van Damme, D. Braeken, G. Callewaert, W.  Robberecht, L. Van Den Bosch,
GluR2 deﬁciency accelerates motor neuron degeneration in a mouse model
of  amyotrophic lateral sclerosis, Journal of Neuropathology and Experimental
Neurology 64 (2005) 605–612.
[161] M. Tateno, H. Sadakata, M.  Tanaka, S. Itohara, R.M. Shin, et al., Calcium-
permeable AMPA receptors promote misfolding of mutant SOD1 protein and
development of amyotrophic lateral sclerosis in a transgenic mouse model,
Human Molecular Genetics 13 (2004) 2183–2196.
[162] A. Spalloni, F. Albo, F. Ferrari, N. Mercuri, G. Bernardi, et al., Cu/Zn-superoxide
dismutase (GLY93→ALA) mutation alters AMPA receptor subunit expression
and function and potentiates kainate-mediated toxicity in motor neurons in
culture, Neurobiology of Disease 15 (2004) 340–350.
[163] J.D. Rothstein, M.  Van Kammen, A.I. Levey, L.J. Martin, R.W. Kuncl, Selective
loss of glial glutamate transporter GLT-1 in amyotrophic lateral sclerosis,
Annals of Neurology 38 (1995) 73–84.
[164] J.D. Rothstein, L.J. Martin, R.W. Kuncl, Decreased glutamate transport by the
brain and spinal cord in amyotrophic lateral sclerosis, New England Journal
of Medicine 326 (1992) 1464–1468.
[165] Y.R.L.B. Tovar, L.D. Santa-Cruz, A. Zepeda, R. Tapia, Chronic elevation of
extracellular glutamate due to transport blockade is innocuous for spinal
motoneurons in vivo, Neurochemistry International 54 (2009) 186–191.
[166] J. Grosskreutz, L. Van Den Bosch, B.U. Keller, Calcium dysregulation in amy-
otrophic lateral sclerosis, Cell Calcium 47 (2010) 165–174.
[167] K. Bianchi, A. Rimessi, A. Prandini, G. Szabadkai, R. Rizzuto, Calcium and mito-
chondria: mechanisms and functions of a troubled relationship, Biochimica
et  Biophysica Acta 1742 (2004) 119–131.
[168] B. Appel, L.A. Givan, J.S. Eisen, Delta-Notch signaling and lateral inhibition in
zebraﬁsh spinal cord development, BMC  Developmental Biology 1 (2001) 13.
[169] A. Fahandejsaadi, E. Leung, R. Rahaii, J. Bu, C. Geula, Calbindin-D28K, parval-
bumin and calretinin in primate lower motor neurons, Neuroreport 15 (2004)
443–448.
[170] G. David, Mitochondrial clearance of cytosolic Ca(2+) in stimulated lizard
motor nerve terminals proceeds without progressive elevation of mitochon-
drial matrix [Ca(2+)], Journal of Neuroscience 19 (1999) 7495–7506.
[171] M.T. Carri, A. Ferri, A. Battistoni, L. Famhy, R. Gabbianelli, et al., Expression of a
Cu,Zn superoxide dismutase typical of familial amyotrophic lateral sclerosis
induces mitochondrial alteration and increase of cytosolic Ca2+ concentra-
tion in transfected neuroblastoma SH-SY5Y cells, FEBS Letters 414 (1997)
365–368.
[172] L.J. Martin, B. Gertz, Y. Pan, A.C. Price, J.D. Molkentin, et al., The mitochondrial
permeability transition pore in motor neurons: involvement in the pathobi-
ology of ALS mice, Experimental Neurology 218 (2009) 333–346.[173] I.G. Kirkinezos, D. Hernandez, W.G. Bradley, C.T. Moraes, An ALS mouse model
with a permeable blood–brain barrier beneﬁts from systemic cyclosporine A
treatment, Journal of Neurochemistry 88 (2004) 821–826.
[174] A.L. Nishimura, M.  Mitne-Neto, H.C. Silva, A. Richieri-Costa, S. Middleton,
et  al., A mutation in the vesicle-trafﬁcking protein VAPB causes late-onset
alcium
[
[
way, Journal of Neurochemistry 114 (2010) 795–809.T. Calì et al. / Cell C
spinal muscular atrophy and amyotrophic lateral sclerosis, American Journal
of  Human Genetics 75 (2004) 822–831.175] K.J. De Vos, G.M. Morotz, R. Stoica, E.L. Tudor, K.F. Lau, et al., VAPB inter-
acts with the mitochondrial protein PTPIP51 to regulate calcium homeostasis,
Human Molecular Genetics 21 (2012) 1299–12311.
176] K. Langou, A. Moumen, C. Pellegrino, J. Aebischer, I. Medina, et al., AAV-
mediated expression of wild-type and ALS-linked mutant VAPB selectively 52 (2012) 73– 85 85
triggers death of motoneurons through a Ca2+-dependent ER-associated path-[177] G.M. Morotz, K.J. De Vos, A. Vagnoni, S. Ackerley, C.E. Shaw, et al., Amyotrophic
lateral sclerosis-associated mutant VAPBP56S perturbs calcium homeostasis
to  disrupt axonal transport of mitochondria, Human Molecular Genetics 21
(2012) 1979–1988.
